Amwill Health Care Limited (BOM:544353)
45.19
+2.54 (5.96%)
At close: Jun 17, 2026
Amwill Health Care Revenue
In the fiscal year ending March 31, 2026, Amwill Health Care had annual revenue of 454.92M INR with 12.10% growth. Amwill Health Care had revenue of 242.87M in the half year ending March 31, 2026.
Revenue
454.92M
Revenue Growth
+12.10%
P/S Ratio
1.99
Revenue / Employee
5.17M
Employees
88
Market Cap
903.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 454.92M | 49.11M | 12.10% |
| Mar 31, 2025 | 405.82M | -33.67M | -7.66% |
| Mar 31, 2024 | 439.48M | 137.82M | 45.69% |
| Mar 31, 2023 | 301.66M | 25.53M | 9.25% |
| Mar 31, 2022 | 276.13M | 96.14M | 53.41% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lactose (India) | 1.63B |
| Makers Laboratories | 1.42B |
| Godavari Drugs | 1.07B |
| Concord Drugs | 787.37M |
| Mercury Laboratories | 759.37M |
| Source Natural Foods and Herbal Supplements | 703.77M |
| Onyx Biotec | 694.69M |
| Phaarmasia | 472.08M |